Close

Grifols (GRFS) Announces FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System

February 7, 2019 12:33 PM EST Send to a Friend
Grifols, (NASDAQ: GRFS) a leading global producer of plasma-derived medicines and a leader in the development of innovative diagnostic solutions ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login